Ticker brief
ATHE
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
4
crowd 14d
+0.10
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-06 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OzmosiHealth | C | · | 2 | +0.03 |
| @CrweWorld | C | · | 1 | +0.05 |
| @PrismMarketView | C | · | 1 | +0.30 |
| @PrismDM | A | -2.76 | 1 | +0.10 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-06 | @OzmosiHealth | +0.00 | Alterity presented Phase 2 ATH-434 multiple-system-atrophy results on 2026-10-05. | · | tweet ↗ |
| 2026-10-05 | @PrismDM | +0.10 | Phase 2 showed adjusted functional benefit but missed the primary MRI endpoint. | · | tweet ↗ |
| 2026-10-05 | @PrismMarketView | +0.30 | Reports mixed Phase 2 data: adjusted functional benefit but a missed primary endpoint. | · | tweet ↗ |
| 2026-10-05 | @OzmosiHealth | +0.05 | Alterity presented new analyses of ATH434 Phase 2 data at a scientific congress. | · | tweet ↗ |
| 2026-10-05 | @CrweWorld | +0.05 | Alterity presents new analyses of Phase 2 ATH434 data without stating results. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.